---
category: news
title: "Flagship company Cellarity takes aim at cell behavior"
excerpt: "The Cambridge, Massachusetts startup is combining artificial intelligence, a protein discovery platform and what it calls “network ... In other areas, the target is valuable, but the small molecule is not. We are disease agnostic and therapy agnostic.” RELATED: Stealthy Insitro opens up—starting with Gilead deal worth up to $1.05B ..."
publishedDateTime: 2019-12-10T09:00:00Z
sourceUrl: https://www.fiercebiotech.com/biotech/flagship-company-cellarity-takes-aim-at-cell-behavior
type: article
quality: 39
heat: 39
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://www.bing.com/th?id=ON.A8A700BD526A2EF0638C31E67D5F71A6
    width: 700
    height: 465
    title: "Flagship company Cellarity takes aim at cell behavior"

secured: "g2meXM/WsUHisUQHCLqPBi4LWt7COErLIcj7EifWyEDtSFgm5gNRqM+SP/Xo7XQ11S20RJtcOHGmhh9m9YMbwhRuvJkQPJIb40iGxSM0IlabJEXktbQj744PnoQfBMXEsd3xEobQvLaHa8xlPRZSNg2t+NU0vQiUUcY6PL9+O5PXso3E0PdRGuiIPGr5m2W/DyW4FCnkfV3ioNw7SJQWwRiE57psNPywQFKZvz04wvrZjdDDNwUudHi3aitwYLGCiCa8ANgowHzB9DfQtvCsrQ==;uClb5zVjmmCO4me7U5BvUg=="
---

